GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
7QTB | P24021 | S1 nuclease from Aspergillus oryzae in complex with cytidine-5'-monophosphate | |
7S07 | P03231 | Crystal structure of Epstein-Barr virus glycoprotein gH/gL/gp42-peptide in complex with human neutralizing antibodies 769B10 and 769C2 | |
7S07 | P03212 | Crystal structure of Epstein-Barr virus glycoprotein gH/gL/gp42-peptide in complex with human neutralizing antibodies 769B10 and 769C2 | |
7S07 | P0C6Z5 | Crystal structure of Epstein-Barr virus glycoprotein gH/gL/gp42-peptide in complex with human neutralizing antibodies 769B10 and 769C2 | |
7S07 | 7S07 | Crystal structure of Epstein-Barr virus glycoprotein gH/gL/gp42-peptide in complex with human neutralizing antibodies 769B10 and 769C2 | |
7S1B | P03231 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | P03212 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | P0C6Z5 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | 7S1B | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7SC5 | A0A6H1VID3 | Cytoplasmic tail deleted HIV Env trimer in nanodisc | |
7SC5 | A0A173DX29 | Cytoplasmic tail deleted HIV Env trimer in nanodisc | |
7SD3 | A0A6H1VID3 | Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs | |
7SD3 | A0A173DX29 | Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs | |
7SD3 | 7SD3 | Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs | |
7UGP | Q2N0S5 | Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 1 | |
7UGP | 7UGP | Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 1 | |
7UGQ | D7S1H2 | Cryo-EM structure of BG24 Fabs with an inferred germline CDRL1 and 10-1074 Fabs in complex with HIV-1 Env 6405-SOSIP.664 | |
7UGQ | 7UGQ | Cryo-EM structure of BG24 Fabs with an inferred germline CDRL1 and 10-1074 Fabs in complex with HIV-1 Env 6405-SOSIP.664 | |
7VTZ | P75733 | Chitoporin from Escherichia coli | |
7VU0 | P75733 | Chitoporin from Escherichia coli | |
7VU1 | P75733 | Chitoporin from Escherichia coli complex with chitohexaose | |
7VU3 | A0A0P0QBS3 | Chitoporin from Serratia marcescens in-complex with chitohexaose | |
7WG3 | 7WG3 | Structural basis of interleukin-17B receptor in complex with a neutralizing antibody D9 for guiding humanization and affinity maturation for cancer therapy | |
7WG3 | A3KN55 | Structural basis of interleukin-17B receptor in complex with a neutralizing antibody D9 for guiding humanization and affinity maturation for cancer therapy | |
7WSH | A0A6J2EID0 | Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 | |
7WSH | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 | |
8A6L | 8A6L | Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs | |
8A6L | Q9UHI5 | Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs | |
8CSC | Q6U8B0 | WbbB D232N-Kdo adduct | |
8CSD | Q6U8B0 | WbbB D232C Kdo adduct | |
8CSE | Q6U8B0 | WbbB in complex with alpha-Rha-(1-3)-beta-GlcNAc acceptor | |
8CSF | Q6U8B0 | WbbB D232C-Kdo adduct + alpha-Rha(1,3)GlcNAc ternary complex | |
8H0X | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-1 Conformation | |
8H0Y | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation | |
8H0Z | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation | |
8H11 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Conformation | |
8H12 | P59594 | Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conformation | |
8H15 | P59594 | Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Closed Conformation | |
8H16 | P59594 | Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation | |
7QBQ | P06276 | Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | |
7QBR | P06276 | Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | |
7QRN | R9TNA6 | Crystal structure of Ovalbumin-related protein X (OVAX) complexed with fondaparinux | |
7SX6 | A0A0M3KKW9 | Crystal structure of broadly neutralizing antibody N49P9.3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
7SX6 | 7SX6 | Crystal structure of broadly neutralizing antibody N49P9.3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
7SX7 | A0A0M3KKW9 | Crystal structure of broadly neutralizing antibody N49P9.3-FR3-3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
7SX7 | 7SX7 | Crystal structure of broadly neutralizing antibody N49P9.3-FR3-3 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core | |
7U6R | A0A1W6ASU7 | Cryo-EM structure of PDF-2180 Spike glycoprotein | |
7WOQ | P0DTC2 | The state 1 of Omicron Spike with bispecific antibody FD01 | |
7WOQ | 7WOQ | The state 1 of Omicron Spike with bispecific antibody FD01 | |
7WOR | P0DTC2 | The state 2 of Omicron Spike with bispecific antibody FD01 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024